Physician profile
William M Duke
NPI 1457442956
$4,338.09
in general payments reported to CMS, 2019-2025
12 companies · $125 in 2025
The $125 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $763 · 2021: $474 · 2022: $1,186 · 2023: $737 · 2024: $489 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,137.16 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $1,053.70 | 2020-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $924.97 | 2020-2024 | Ofev |
| Acadia Pharmaceuticals INC | $387.57 | 2022-2024 | Nuplazid |
| Astrazeneca Pharmaceuticals LP | $254.57 | 2021-2023 | Lokelma |
| Insmed, INC. | $237.33 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $125.00 | 2019 | |
| Mylan Specialty L.P. | $112.40 | 2019 | |
| Qiagen, LLC | $33.29 | 2020 | |
| Pfizer INC. | $31.93 | 2019 | |
| Novo Nordisk INC | $20.29 | 2024 | |
| Abbvie INC. | $19.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Duke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.